Capivasertib plus fulvestrant versus placebo plus fulvestrant in metastatic ER positive breast cancer (FAKTION): A randomised, double-blind, placebo-controlled, phase II trial
Jones, R Carucci, M Casbard, A Butler, R Bale, C Alchami, F Bezecny, P Joffe, J Moon, S Twelves, C
Jones, R
Carucci, M
Casbard, A
Butler, R
Bale, C
Alchami, F
Bezecny, P
Joffe, J
Moon, S
Twelves, C
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Jones R, Carucci M, Casbard A, Butler R, Bale C, Alchami F, et al. Capivasertib plus fulvestrant versus placebo plus fulvestrant in metastatic ER positive breast cancer (FAKTION): A randomised, double-blind, placebo-controlled, phase II trial. British Journal of Cancer. 2019;121:19